Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CDE vs GSK✓SelectedUSD · GSKCDE vs GSK performance historyLatest closeAs of-7.06%11/18
Stock and ETF performance explorer

CDE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+91.5%
GSK return
+41.8%
Excess return
+49.7%
Maximum drawdown
-68.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.1%-1.3%-5.7%-6.6%
7D-18.6%-3.1%-15.4%-17.7%
30D-20.2%-0.9%-19.3%-20.0%
3M-33.9%-4.2%-29.7%-33.0%
6M-30.0%-1.6%-28.4%-30.1%
YTD-31.3%+2.6%-33.9%-32.6%
1Y-14.8%+6.2%-21.0%-17.6%
3Y+386.3%+55.0%+331.3%+267.0%
All+91.5%+41.8%+49.7%+32.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling